Summary
In this short article for an Australian nursing magazine, New Zealand mental health nurse Jason Watson challenges the idea that withholding gender-affirming treatment from young people drives them to suicide. He looks at six large, long-term studies from the Netherlands, Sweden, Denmark, the UK and Finland. In his reading, suicide rates among transgender people stayed well above the general population after treatment, rates fell over time only for trans women in one Dutch study, and the Tavistock clinic review found no rise in youth suicides after access to puberty blockers was restricted in England. He concludes that the 'transition or suicide' claim is weak at best. The article was printed in July 2026, then removed from the journal's website after complaints; the nurses' union apologised for publishing it but later said this did not imply misconduct by the author. It is an opinion piece, not a systematic review: it picks a handful of studies, most of them about adults, and some of its readings go further than the studies' own authors. For example, the Finnish study it relies on most concluded that suicide risk was explained by mental illness and that gender reassignment did not change suicide risk either way.
Key findings
- Watson은 성별 긍정 치료를 받지 못한 청소년의 자살 위험이 더 높다는, WPATH와 미국 보건 당국자들이 되풀이해 온 주장에 의문을 제기합니다.
- 그는 네덜란드, 스웨덴, 덴마크, 영국, 핀란드의 장기 추적 연구 여섯 건을 검토합니다. 이 연구들은 대상자가 324명에서 15,000명 이상, 추적 기간이 5년에서 46년까지 다양합니다.
- 그는 트랜스젠더 사람들의 자살률과 사망률이 치료 후에도 일반 인구보다 높은 수준으로 유지되었고, 시간이 지나며 자살이 줄어든 것으로 나타난 연구는 트랜스 여성을 대상으로 한 네덜란드 연구 한 건뿐이라고 보고합니다.
- 그는 영국 Tavistock 클리닉의 자살 사례 검토를 강조합니다. 이 검토에서는 자살이 12건 확인되었고, 급증할 것이라는 예측과 달리 사춘기 차단제가 제한된 뒤에도 청소년 자살이 늘지 않았습니다.
- 그는 이 분야의 연구 대부분이 질이 낮다는 Cass Review의 결론과 같은 맥락에서, '전환 아니면 자살'이라는 서사가 '적어도 근거가 빈약하고, 심하게는 단순히 틀린 것'이라고 결론짓습니다.
- 호주 간호사 노동조합은 2026년 7월 학술지 웹사이트에서 이 기사를 삭제하고 게재에 대해 사과했으며, 이후 이것이 저자의 부정행위를 인정한 것은 아니라고 밝혔습니다.
Abstract
This short article examines the narrative that trans youth who are not provided with gender-affirming healthcare face an increased risk of suicide, a view stated by WPATH's Standards of Care 8 and the US Assistant Secretary for Health in 2022. Noting the Cass Review's finding that research in this field is of poor quality, the author summarises six long-term follow-up studies from the Netherlands (Wiepjes 2020; de Blok 2021), Sweden (Dhejne 2011), Denmark (Erlangsen 2023), England (Appleby 2024, a review of suicides among Tavistock gender clinic patients) and Finland (Ruuska 2024), with sample sizes from 324 to 15,032 and follow-up from five to 46 years, and describes what each reported about suicide and mortality.
Conclusion
Only one finding, the decline in suicide among trans women over time in Wiepjes (2020), appeared to support the narrative that lack of access to gender-affirming care increases suicide risk. The author argues the other studies showed no evidence that treatment reduced suicidal behaviour, and reported higher 'other' mortality after treatment, and that Ruuska (2024), the only study with a matched control group, found much higher suicide and overall mortality among trans people. He concludes the 'trans suicide narrative' is 'at least tenuous and at most simply incorrect', consistent with the Cass Review's view that most research in this field is of poor quality.